Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis

BACKGROUND: Several clinical and experimental lines of evidence suggest that leucotriene B4 (LTB4), an arachidonic acid derivative with potent proinflammatory properties, plays a key role in the pathophysiology of rheumatoid arthritis (RA). OBJECTIVE: To evaluate the efficacy and safety of BIIL 284,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Díaz‐González, Federico, Alten, Rieke H E, Bensen, William G, Brown, Jacques P, Sibley, John T, Dougados, Maxime, Bombardieri, Stefano, Durez, Patrick, Ortiz, Pablo, de‐Miquel, Gonzalo, Staab, Alexander, Sigmund, Ralf, Salin, Laurence, Leledy, Caroline, Polmar, Stephen H
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2007
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954613/
https://ncbi.nlm.nih.gov/pubmed/17170051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.062554
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars